242 related articles for article (PubMed ID: 26230883)
1. Biological characteristics and agonists of GPR120 (FFAR4) receptor: the present status of research.
Li A; Li Y; Du L
Future Med Chem; 2015; 7(11):1457-68. PubMed ID: 26230883
[TBL] [Abstract][Full Text] [Related]
2. GPR120 agonism as a countermeasure against metabolic diseases.
Cornall LM; Mathai ML; Hryciw DH; McAinch AJ
Drug Discov Today; 2014 May; 19(5):670-9. PubMed ID: 24315954
[TBL] [Abstract][Full Text] [Related]
3. Free fatty acid receptor GPR120 and pathogenesis of obesity and type 2 diabetes mellitus.
Mo XL; Wei HK; Peng J; Tao YX
Prog Mol Biol Transl Sci; 2013; 114():251-76. PubMed ID: 23317787
[TBL] [Abstract][Full Text] [Related]
4. A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice.
Oh DY; Walenta E; Akiyama TE; Lagakos WS; Lackey D; Pessentheiner AR; Sasik R; Hah N; Chi TJ; Cox JM; Powels MA; Di Salvo J; Sinz C; Watkins SM; Armando AM; Chung H; Evans RM; Quehenberger O; McNelis J; Bogner-Strauss JG; Olefsky JM
Nat Med; 2014 Aug; 20(8):942-7. PubMed ID: 24997608
[TBL] [Abstract][Full Text] [Related]
5. GPR120 agonists for the treatment of diabetes: a patent review (2014 present).
Zhang X; Macielag MJ
Expert Opin Ther Pat; 2020 Oct; 30(10):729-742. PubMed ID: 32799609
[TBL] [Abstract][Full Text] [Related]
6. GPR120: a critical role in adipogenesis, inflammation, and energy metabolism in adipose tissue.
Song T; Yang Y; Zhou Y; Wei H; Peng J
Cell Mol Life Sci; 2017 Aug; 74(15):2723-2733. PubMed ID: 28285320
[TBL] [Abstract][Full Text] [Related]
7. GPR120/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery.
Carullo G; Mazzotta S; Vega-Holm M; Iglesias-Guerra F; Vega-Pérez JM; Aiello F; Brizzi A
J Med Chem; 2021 Apr; 64(8):4312-4332. PubMed ID: 33843223
[TBL] [Abstract][Full Text] [Related]
8. Revisiting PPARγ as a new friend of GPR120 in the treatment of metabolic disorders.
Paschoal VA; Oh DY
Adipocyte; 2020 Dec; 9(1):649-652. PubMed ID: 33108252
[TBL] [Abstract][Full Text] [Related]
9. GPR120: Mechanism of action, role and potential for medical applications.
Karakuła-Juchnowicz H; Róg J; Juchnowicz D; Morylowska-Topolska J
Postepy Hig Med Dosw (Online); 2017 Nov; 71(0):942-953. PubMed ID: 29176006
[TBL] [Abstract][Full Text] [Related]
10. Potential roles of GPR120 and its agonists in the management of diabetes.
Zhang D; Leung PS
Drug Des Devel Ther; 2014; 8():1013-27. PubMed ID: 25114508
[TBL] [Abstract][Full Text] [Related]
11. FFA4 receptor (GPR120): A hot target for the development of anti-diabetic therapies.
Liu HD; Wang WB; Xu ZG; Liu CH; He DF; Du LP; Li MY; Yu X; Sun JP
Eur J Pharmacol; 2015 Sep; 763(Pt B):160-8. PubMed ID: 26123847
[TBL] [Abstract][Full Text] [Related]
12. IL-1β and TNFα inhibit GPR120 (FFAR4) and stimulate GPR84 (EX33) and GPR41 (FFAR3) fatty acid receptor expression in human adipocytes: implications for the anti-inflammatory action of n-3 fatty acids.
Muredda L; Kępczyńska MA; Zaibi MS; Alomar SY; Trayhurn P
Arch Physiol Biochem; 2018 May; 124(2):97-108. PubMed ID: 28835131
[TBL] [Abstract][Full Text] [Related]
13. Omega 3 fatty acids and GPR120.
Oh DY; Olefsky JM
Cell Metab; 2012 May; 15(5):564-5. PubMed ID: 22560206
[TBL] [Abstract][Full Text] [Related]
14. Discovery of N-arylpyrroles as agonists of GPR120 for the treatment of type II diabetes.
Winters MP; Sui Z; Wall M; Wang Y; Gunnet J; Leonard J; Hua H; Yan W; Suckow A; Bell A; Clapper W; Jenkinson C; Haug P; Koudriakova T; Huebert N; Murray WV
Bioorg Med Chem Lett; 2018 Mar; 28(5):841-846. PubMed ID: 29456108
[TBL] [Abstract][Full Text] [Related]
15. Expression and localization of the omega-3 fatty acid receptor GPR120 in human term placenta.
Lager S; Ramirez VI; Gaccioli F; Jansson T; Powell TL
Placenta; 2014 Jul; 35(7):523-5. PubMed ID: 24844436
[TBL] [Abstract][Full Text] [Related]
16. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects.
Oh DY; Talukdar S; Bae EJ; Imamura T; Morinaga H; Fan W; Li P; Lu WJ; Watkins SM; Olefsky JM
Cell; 2010 Sep; 142(5):687-98. PubMed ID: 20813258
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic potential of GPR120: a patent review.
Halder S; Kumar S; Sharma R
Expert Opin Ther Pat; 2013 Dec; 23(12):1581-90. PubMed ID: 24094095
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a potent and selective GPR120 agonist.
Shimpukade B; Hudson BD; Hovgaard CK; Milligan G; Ulven T
J Med Chem; 2012 May; 55(9):4511-5. PubMed ID: 22519963
[TBL] [Abstract][Full Text] [Related]
19. Diabetes: Gpr120 agonist has anti-inflammatory and insulin-sensitizing effects.
Greenhill C
Nat Rev Endocrinol; 2014 Sep; 10(9):510. PubMed ID: 25048034
[No Abstract] [Full Text] [Related]
20. Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases.
Talukdar S; Olefsky JM; Osborn O
Trends Pharmacol Sci; 2011 Sep; 32(9):543-50. PubMed ID: 21663979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
